Stefan Goemaere

机构：Ghent University Hospital

发表论文 319 篇 · 总被引 14841 次 · h-index 64

代表论文

• Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial (2017 · The Lancet · 被引 491)
• A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis (2018 · The Journal of Clinical Endocrinology & Metabolism · 被引 329)
• Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study (2018 · Journal of Bone and Mineral Research · 被引 241)
• Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study (2019 · The Lancet Diabetes & Endocrinology · 被引 173)
• BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial (2017 · Journal of Bone and Mineral Research · 被引 150)
• Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services (2021 · Osteoporosis International · 被引 141)